Stay updated on Dupilumab in CSU Patients Unresponsive to Omalizumab Clinical Trial
Sign up to get notified when there's something new on the Dupilumab in CSU Patients Unresponsive to Omalizumab Clinical Trial page.

Latest updates to the Dupilumab in CSU Patients Unresponsive to Omalizumab Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedThe Study Locations section was updated with many new sites across the US, Canada, Argentina, France, Germany, Japan, Spain, and the UK, and several existing sites were removed. This expands and refines the recruitment footprint across multiple countries.SummaryDifference2%

- Check24 days agoNo Change Detected
- Check32 days agoChange DetectedA new PubMed citation has been added to the Publications section: 'Dupilumab Improves Health-Related Quality of Life in Omalizumab-Naive Patients with Chronic Spontaneous Urticaria' (Dermatol Ther (Heidelb), online ahead of print, 2025 Dec 2, doi:10.1007/s13555-025-01605-w). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check46 days agoChange DetectedPublications added to the Publications section include a 2025 article on dupilumab and CSU. The page also notes Revision: v3.3.2.SummaryDifference0.1%

- Check53 days agoChange DetectedDeleted the general government funding operating-status notice from the page. The notice did not pertain to the study details or user actions.SummaryDifference0.2%

- Check67 days agoChange DetectedNo significant additions or deletions are visible between the two screenshots. The page content, including study details and location listings, remains unchanged.SummaryDifference0.2%

- Check96 days agoChange Detected- Removed version v3.1.0 and added a new version tag v3.2.0 along with an important notice about government funding and operating status of the NIH Clinical Center.SummaryDifference1%

Stay in the know with updates to Dupilumab in CSU Patients Unresponsive to Omalizumab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dupilumab in CSU Patients Unresponsive to Omalizumab Clinical Trial page.